Renal cell carcinoma, which presents as cystic RCC, was frequently observed in the extremely enlarged kidneys. settings. We further shown that these phenotypes were caused by inactivation ofBHDand subsequent activation of the mTOR pathway. Software of rapamycin, which inhibits mTOR activity, to the affected mice led to extended survival and inhibited further progression of cystogenesis. These results provide a correlation of kidney-targeted gene inactivation with renal carcinoma, and they suggest that theBHDproduct FLCN, functioning like a cyst and tumor suppressor, like additional hamartoma syndromerelated proteins such as PTEN, LKB1, and TSC1/2, is definitely a component of the mTOR pathway, constituting a novel PTGS2 FLCN-mTOR signaling branch that regulates cell growth/proliferation. == Intro == BirtHoggDub (BHD) syndrome is an autosomal dominating genetic disease characterized by fibrofolliculomas (follicular hamartomas), renal cell carcinomas, spontaneous pneumothorax, and lung cysts[1]. Renal cysts were also observed in some individuals[2],[3]. TheBHDgene (accession quantity,BC015687), located on chromosome 17p11.2, contains 14 exons spanning approximately 20 kb of genomic DNA and encodes a protein of 579 amino acids, folliculin (FLCN) that has no known functional domains[4],[5],[6]. Germ-line mutations, somatic alterations, and loss ofBHDmRNA have been observed in individuals with BHD, colorectal malignancy, and in some cases of gastric malignancy; thus,BHDmay be viewed as a candidate tumor-suppressor gene[7],[8],[9],[10]. Germ-line mutations of the counterpartBHDhave also been recognized in dogs and rats having renal cell carcinomas and renal multiple cysts[11],[12],[13]. As one of the hamartoma syndromes, BHD shares many medical features (such as follicular hamartomas, mucosal fibromas, and internal malignancy) with Cowden syndrome (CD, affected genePTEN), Procainamide HCl Peutz-Jeghers syndrome (PJS, affected geneLKB1), and tuberous sclerosis complex (affected genesTSC1/TSC2)[14],[15],[16]. Of these, Cowden syndrome shares the most medical features with BHD. While PTEN, LKB1, and TSC1/2 are crucial members of the mTOR pathway[17], theBHDprotein FLCN has also been suggested to be involved[18],[19]. These findings imply that FLCN, like PTEN, may also be a pivotal tumor suppressor gene and a potential player in mTOR pathway. Over the last few years, desire for FLCN has grown significantly. A few model organisms have been used to explore the physiological part of FLCN. However, these studies offered discrepant results, which leave the function of FLCN elusive. InDrosophila, the Bhd homologue was linked to JAK-STAT and Dpp pathway[20]. Anin vitroexperiment exposed that FLCN interacts with AMPK in mammalian cell lines, associating FLCN with the mTOR pathway[18], whereas in fission candida, Bhd was reported to activate the mTOR counterpart Tor2, showing an opposite part to Tsc1/2[19]. Since noin vitroexperiments or nonmammalian model can replicate the complex processes of tumorigenesis in humans, the development ofBHD-deficient animal models will shed light Procainamide HCl on the part ofBHD in vivoand on Procainamide HCl theBHD-related biochemical pathways responsible for neoplasia, which eventually could lead to the development of restorative providers againstBHD-related diseases. Although natural mutants could Procainamide HCl be utilized for experimental models, the possibilities of homozygous embryonic lethality and additional unknown genetic changes often impede further analysis of the phenotypes and the physiological part of the gene. The genetically designed conditional knockout mouse model can bypass this barrier and provide a cleaner and more versatile system for functional studies ofBHDgene protein FLCN. While it might be a suppressor of mouse cystogenesis shown by a recent study[21],BHDis expected to be a potential tumor suppressor gene whose mutations have led to renal tumors and additional diseases in BHD individuals. Therefore, it is essential to further elucidate whether kidney-specific knockout ofBHDin the mouse is also implicated in kidney tumorigenesis, and what mechanism is involved. == Results == == Generation ofBHDconditional knockout create and mice == To generate a conditional knockout create, we used the MultiSite GatewayThree-Fragment Vector Building system (Invitrogen, Carlsbad, CA) to inactivate theBHDgene by deleting exons 3 and 4 (Number 1A). The create was electroporated into 129/Sv strain embryonic stem (Sera) cells. Correctly targeted Sera cell clones were obtained after becoming selected with G418, screened by long-range PCR, and confirmed using PCR and Southern blot analysis (Number 1BE). For the generation of chimeras, Sera cells heterozygous for theBHD-floxed allele Procainamide HCl were injected into.
Renal cell carcinoma, which presents as cystic RCC, was frequently observed in the extremely enlarged kidneys
